fda warning letter bpc-157 unapproved new drug advisers back first four of seven peptides under review for looser rules | The Mighty 790 KFGO FDA panel backs compounded BPC-157,

Fatty acid oxidation is required for active and quiescent brown adipose tissue maintenance and thermogenic programing

Sleep improvements fade after 2-4 months without repeat cycle

Key Regulatory Points as of 2026: Not FDA-approved for any medical indication Cannot legally be sold as a drug, food, or dietary supplement for human consumption Legally sold as a "research chemical," not intended for human use Not a DEA-scheduled substance, so possession is not illegal (unlike anabolic steroids) Many medical clinics offer BPC-157 treatments despite lack of approval The FDA has expressed safety concerns due to the lack of human clinical trial data and the potential for adverse effects from unregulated manufacturing

& Robbins, PD